New pill could fight dangerous fungal infections
Disease control
Terminated
This study tested a new oral antifungal drug, ibrexafungerp, for treating serious Candida infections in the blood or internal organs. 68 adults received an IV antifungal followed by either ibrexafungerp or standard oral fluconazole. The trial was stopped early, so the results are…
Phase: PHASE3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC